
生物醫藥技術全國重點實驗室
(香港大學)
State Key Laboratory of Pharmaceutical Biotechnology
(The University of Hong Kong)

Field of Research
Biomarker discovery and multi-omics analyses in cardiometabolic disorders
Biography
Dr. Chloe Cheung obtained her BSc in Human Genetics from University College London in 2006, and later completed a MSc in Human Molecular Genetics from Imperial College London in the United Kingdom in 2007. She completed her PhD in Genetic Epidemiology in 2012, followed by an MPH in 2017, both from the University of Hong Kong. After finishing her postdoctoral training in 2016, she was promoted to Research Assistant Professor in the Department of Medicine at the School of Clinical Medicine, University of Hong Kong. Dr. Cheung's research focuses on discovering novel biomarkers for cardiometabolic diseases. Using multi-omics platforms, she has successfully identified genetic and circulating biomarkers for type 2 diabetes and its related complications. Her research results have been published in several international peer-reviewed journals, including Nature Communications, Diabetes Care, Diabetologia, Diabetes, Cardiovascular Diabetology, and Journal of Advanced Research.
